Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2004 1
2005 4
2006 4
2007 3
2008 1
2009 3
2010 1
2011 3
2012 4
2013 2
2014 1
2015 2
2016 3
2017 5
2018 3
2019 6
2020 3
2021 2
2022 1
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
Tsuboi M, Herbst RS, John T, Kato T, Majem M, Grohé C, Wang J, Goldman JW, Lu S, Su WC, de Marinis F, Shepherd FA, Lee KH, Le NT, Dechaphunkul A, Kowalski D, Poole L, Bolanos A, Rukazenkov Y, Wu YL; ADAURA Investigators. Tsuboi M, et al. N Engl J Med. 2023 Jul 13;389(2):137-147. doi: 10.1056/NEJMoa2304594. Epub 2023 Jun 4. N Engl J Med. 2023. PMID: 37272535 Clinical Trial.
Comprehensive circulating microRNA profile as a supersensitive biomarker for early-stage lung cancer screening.
Inagaki M, Uchiyama M, Yoshikawa-Kawabe K, Ito M, Murakami H, Gunji M, Minoshima M, Kohnoh T, Ito R, Kodama Y, Tanaka-Sakai M, Nakase A, Goto N, Tsushima Y, Mori S, Kozuka M, Otomo R, Hirai M, Fujino M, Yokoyama T. Inagaki M, et al. Among authors: yokoyama t. J Cancer Res Clin Oncol. 2023 Sep;149(11):8297-8305. doi: 10.1007/s00432-023-04728-9. Epub 2023 Apr 19. J Cancer Res Clin Oncol. 2023. PMID: 37076642 Free PMC article.
Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study.
Murata Y, Tanzawa S, Misumi T, Yoshioka H, Miyauchi E, Ninomiya K, Takeshita M, Ito K, Okamoto T, Sugawara S, Kawashima Y, Hashimoto K, Mori M, Miyanaga A, Hayashi A, Tanaka H, Honda R, Nojiri M, Sato Y, Hata A, Masuda K, Kozuki T, Kawamura T, Suzuki T, Yamaguchi T, Asada K, Tetsumoto S, Tanaka H, Watanabe S, Umeda Y, Yamaguchi K, Kuyama S, Tsuruno K, Misumi Y, Kuraishi H, Yoshihara K, Nakao A, Kubo A, Yokoyama T, Watanabe K, Seki N. Murata Y, et al. Among authors: yokoyama t. JTO Clin Res Rep. 2023 Oct 20;4(12):100593. doi: 10.1016/j.jtocrr.2023.100593. eCollection 2023 Dec. JTO Clin Res Rep. 2023. PMID: 38046378 Free PMC article.
Femtosecond Charge Density Modulations in Photoexcited CuWO4.
Uemura Y, Ismail ASM, Park SH, Kwon S, Kim M, Niwa Y, Wadati H, Elnaggar H, Frati F, Haarman T, Höppel N, Huse N, Hirata Y, Zhang Y, Yamagami K, Yamamoto S, Matsuda I, Katayama T, Togashi T, Owada S, Yabashi M, Halisdemir U, Koster G, Yokoyama T, Weckhuysen BM, de Groot FMF. Uemura Y, et al. Among authors: yokoyama t. J Phys Chem C Nanomater Interfaces. 2021 Apr 8;125(13):7329-7336. doi: 10.1021/acs.jpcc.0c10525. Epub 2021 Mar 26. J Phys Chem C Nanomater Interfaces. 2021. PMID: 33859771 Free PMC article.
57 results